European Union -
English -
EMA (European Medicines Agency)
ninlaro
takeda pharma a/s - ixazomib citrate - multiple myeloma - antineoplastic agents - ninlaro in combination with lenalidomide and dexamethasone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.
Canada -
English -
Health Canada
ninlaro capsule
takeda canada inc - ixazomib (ixazomib citrate) - capsule - 2.3mg - ixazomib (ixazomib citrate) 2.3mg - antineoplastic agents
Canada -
English -
Health Canada
ninlaro capsule
takeda canada inc - ixazomib (ixazomib citrate) - capsule - 3mg - ixazomib (ixazomib citrate) 3mg - antineoplastic agents
Canada -
English -
Health Canada
ninlaro capsule
takeda canada inc - ixazomib (ixazomib citrate) - capsule - 4mg - ixazomib (ixazomib citrate) 4mg - antineoplastic agents